ZYVERSA THERAPEUTICS INC (ZVSA) Stock Balance Sheet
NASDAQ:ZVSA - Nasdaq - US98987D3008 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.61M | 1.53M | 3.14M | 5.90M | 329.00K | |||
| Other Current Assets | 498.80K | 184.90K | 215.00K | 460.00K | 483.00K | |||
| Total Current Assets | 2.11M | 1.72M | 3.35M | 6.36M | 812.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 0.00 | 15.00K | 116.00K | 28.00K | |||
| Goodwill | N/A | N/A | 0.00 | 11.89M | 0.00 | |||
| Intangibles | 18.65M | 18.65M | 18.65M | 100.09M | 0.00 | |||
| Other Non-Current Assets | 227.30K | 235.70K | 98.00K | 47.00K | 287.00K | |||
| Total Non-Current Assets | 18.88M | 18.88M | 18.76M | 112.14M | 314.00K | |||
| TOTAL ASSETS | 20.99M | 20.60M | 22.11M | 118.51M | 1.13M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 9.15M | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 2.40M | 1.89M | 1.76M | 2.06M | 1.91M | |||
| Accounts Payable | 9.60M | 9.34M | 8.43M | 6.03M | 2.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | 107.00K | 561.00K | |||
| Total Current Liabilities | 12.00M | 11.23M | 10.20M | 8.19M | 13.63M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 851.70K | 851.70K | 845.00K | 10.32M | 0.00 | |||
| Total Non-Current Liabilities | 851.70K | 851.70K | 845.00K | 10.32M | 0.00 | |||
| TOTAL LIABILITIES | 12.86M | 12.08M | 11.04M | 18.51M | 13.63M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -114.89M | -112.63M | -103.22M | -4.92M | -52.90M | |||
| Additional Paid In Capital | 123.03M | 121.16M | 114.30M | 104.58M | 40.06M | |||
| Common Shares | 300.00 | 300.00 | 0.00 | 332.00K | 332.00K | |||
| Treasury Stock | -7.20K | -7.20K | -7.00K | N/A | N/A | |||
| Shares Outstanding | 2.57M | 2.51M | 405.00K | 26.00K | 26.00K | |||
| Tangible Book Value per Share | -4.10 | -4.04 | -18.70 | -461.04 | -480.77 | |||
| Total Shareholders' Equity | 8.13M | 8.52M | 11.07M | 99.99M | -12.50M | |||
| TOTAL LIABILITIES AND EQUITY | 20.99M | 20.60M | 22.11M | 118.51M | 1.13M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.18 | 0.15 | 0.33 | 0.78 | 0.06 | |||
| Return On Assets (ROA) | -42.14% | -45.70% | -480.45% | -20.37% | -717.96% | |||
| Return On Equity (ROE) | -108.77% | -110.53% | -959.33% | -24.14% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21